Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지

Histopathological Features of Lymphoma in Yogyakarta, Indonesia

  • Published : 2016.09.01
⟨ Previous Next ⟩

Abstract

The incidence and prevalence, the second most common lymphoid malignancy after leukemia, are both increasing. The distribution of lymphoma varies among sexes, age groups, and sites. In Indonesia, information about the incidence of lymphoma and its characteristics are insufficient. Therefore, this study was performed to evaluate the incidence of lymphoma and features based on age group, sex, site, clinical diagnosis, and histopathological type in Indonesia. This study is an observational analytical study with a cross-sectional design aimed to evaluate the histopathological profile of lymphoma in Yogyakarta from 2010-2014. It was based on secondary data from Anatomic Pathology Department's medical records from several hospitals and laboratories. The result showed an increased incidence of lymphoma in Yogyakarta in 2010-2014 (p=0.039). Lymphoma mostly occurred in age range 45-64 years (p=0.004), dominated by male with ratio 1.6:1. DLBCL was found to be the most common histopathological type (44.4%). Sex, age, and clinical diagnosis demonstrated statistically significant correlations with the histopathological type (p<0.001). In conclusion, the incidence of lymphoma has significantly increased from 2010-2014. There are statistically significant correlations between gender, age, and clinical diagnosis with the histopathological type of lymphoma.

Keywords

References

  1. Antoro EL, Dwianingsih EK, Indrawati, et al (2016). The polymerase chain reaction in diagnosis of small B-cell non-Hodgkin lymphomas. Asian Pac J Cancer Prev, 17, 491-5. https://doi.org/10.7314/APJCP.2016.17.2.491
  2. Bassig BA, Au WY, Mang O, et al (2016). Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001-2010. Cancer Epidemiol, 42, 15-23. https://doi.org/10.1016/j.canep.2016.02.007
  3. Boediwarsono (2000). A problem of malignant lymphoma management in Indonesia. Folia Medica Indonesiana, 36, 32-7.
  4. Boffetta P (2011). Epidemiology of adult non-Hodgkin lymphoma. Ann Oncol, 22, 27-31. https://doi.org/10.1093/annonc/mdr287
  5. Fan R, Zhang LY, Wang H, et al (2012). Multicentre hospital-based case-control study of diffuse large B-cell lymphoma in Shanghai, China. Asian Pac J Cancer Prev, 13, 3329-34. https://doi.org/10.7314/APJCP.2012.13.7.3329
  6. GloghiniA, Dolcetti R, Carbone A (2013). Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology. Semin Cancer Biol, 23, 457-67. https://doi.org/10.1016/j.semcancer.2013.08.004
  7. Hillman RS, Ault KA, Leporrier M, et al 2011. Hematology in Clinical Practice, USA, McGraw-Hill.
  8. Hoppe RT, Mauch PT, Armitage JO, et al 2007, Hodgkin Lymphoma, Philadephia, Lippincott Williams & Wilkins.
  9. Horesh N, Horowitz NA (2014). Does gender matter in non-hodgkin lymphoma? Differences in epidemiology, clinical behavior, and therapy. Rambam Maimonides Med J, 5, e0038. https://doi.org/10.5041/RMMJ.10172
  10. Huh J (2012). Epidemiologic overview of malignant lymphoma. Korean J Hematol, 47, 92-104. https://doi.org/10.5045/kjh.2012.47.2.92
  11. Kumar V, Abbas AK, Aster JC (2013). Hematopoietic and lymphoid system. In 'Robbins Basic Pathology', Eds Elsevier Saunders, Canada, 429-58
  12. Longo DL(2012). Malignancies of lymphoid cells. In'Harrison's principle of internal medicine ', Eds Me Graw Hill, USA McGraw Hill, USA, 919-35
  13. Morton LM, Hartge P, Holford TR, et al (2005). Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev, 14, 925-33. https://doi.org/10.1158/1055-9965.EPI-04-0693
  14. Morton LM, Wang SS, Devesa SS, et al (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood, 107, 265-76. https://doi.org/10.1182/blood-2005-06-2508
  15. Naz E, Mirza T, Aziz S, et al (2011). Frequency and clinicopathologic correlation of different types of non Hodgkin's lymphoma according to WHO classification J Pak Med Assoc, 61, 260-3.
  16. Reksodiputro AH (2015). Multicentre epidemiology and survival study of B cell non Hodgkin lymphoma patients in Indonesia. J Blood Disorders Transfusion, 6, 1-5.
  17. Sabatine MS 2011. Pocket Medicine, Philadephia, Lippincott Williams & Wilkins.
  18. Siegel R, NaishadhamD, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
  19. Soenarto D, Soekamto S, Koesoemowardoyo (1977). Malignant lymphoma in Surabaya. Mod Med Asia, 13, 5-6.
  20. Timan IS, Aulia D, Atmakusma D, et al (2002). Some hematological problems in Indonesia. Int J Hematol, 76, 286-90. https://doi.org/10.1007/BF03165264
  21. Wada N, Ham MF, Fujita S, et al (2008). Malignant lymphomas in Waldeyer's ring in Asian countries: Association with histologic types and Epstein-Barr virus. Mol Med Rep, 1, 651-5.
  22. Ward E, DeSantis C, Robbins A, et al (2014). Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin, 64, 83-103. https://doi.org/10.3322/caac.21219